Medplus IPO Review 7 Point Analysis
Published on 13 December 2021
Medplus is the 2nd largest pharmacy retailer in India in terms of revenues and number of stores with a retail network of over 2000 stores across the country. The company is an omni channel player – Having a physical as well as online presence. The IPO opens from 13th December to 15th December 2021 with a total issue size of Rs. 1,398 Cr which includes a fresh issue of Rs. 600 Cr and Rs. 798 Cr of the issue being an offer for sale.
Here is a 7 point analysis of Medplus IPO Review attached below.
You like to know more. We like that!
Please subscribe Model Portfolio Plan to get access of all premium model portfolio articles Only at Rs. 11,999.00/Year.
Please login to view this free article.
This blog is available only for logged in users, please register and get access to view this article.